New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5
- PMID: 23318698
- DOI: 10.1097/MNH.0b013e32835cecf8
New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5
Abstract
Purpose of review: Primary aldosteronism is a major cause of secondary hypertension worldwide. This review describes the recent studies that have provided dramatic new insight into the pathogenesis of aldosterone-producing adenomas (APAs) and inherited primary aldosteronism, revealing the role of mutations in the potassium channel KCNJ5 in these disorders.
Recent findings: Either of two somatic gain-of-function mutations in the inward rectifier potassium channel KCNJ5 (Kir3.4) are present in approximately 40% of APAs. These tumor-causing mutations are heterozygous and alter the channel's selectivity filter. Mutant channels gain permeability to sodium, resulting in cellular depolarization and activation of voltage-gated calcium channels. The resulting calcium influx is sufficient to produce aldosterone secretion and cell proliferation, accounting for APA development. Germline KCNJ5 mutations also result in either of two autosomal-dominant syndromes featuring early-onset primary aldosteronism. Mutations identical or similar to those found in APAs result in massive bilateral adrenal hyperplasia. A different mutation at the same position produces a less severe syndrome without adrenal hyperplasia because this mutation results in Na-dependent cell lethality caused by a drastic increase in Na conductance.
Summary: These findings provide fundamental insight into the pathogenesis of APAs and primary aldosteronism, and have implications for new diagnostic and therapeutic strategies.
Similar articles
-
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.Science. 2011 Feb 11;331(6018):768-72. doi: 10.1126/science.1198785. Science. 2011. PMID: 21311022 Free PMC article.
-
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30. Hypertension. 2014. PMID: 24082052
-
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27. Hypertension. 2014. PMID: 24866132
-
An update on novel mechanisms of primary aldosteronism.J Endocrinol. 2015 Feb;224(2):R63-77. doi: 10.1530/JOE-14-0597. Epub 2014 Nov 25. J Endocrinol. 2015. PMID: 25424518 Review.
-
Novel genes in primary aldosteronism.Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):154-8. doi: 10.1097/MED.0000000000000060. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 24739312 Review.
Cited by
-
Potassium Channels as a Target for Cancer Therapy: Current Perspectives.Onco Targets Ther. 2022 Jul 20;15:783-797. doi: 10.2147/OTT.S326614. eCollection 2022. Onco Targets Ther. 2022. PMID: 35899081 Free PMC article. Review.
-
Two-pore domain potassium channels in the adrenal cortex.Pflugers Arch. 2015 May;467(5):1027-42. doi: 10.1007/s00424-014-1628-6. Epub 2014 Oct 23. Pflugers Arch. 2015. PMID: 25339223 Free PMC article. Review.
-
Overview of the genetic determinants of primary aldosteronism.Appl Clin Genet. 2014 Apr 8;7:67-79. doi: 10.2147/TACG.S45620. eCollection 2014. Appl Clin Genet. 2014. PMID: 24817817 Free PMC article. Review.
-
Advances in the molecular imaging of primary aldosteronism.Ann Nucl Med. 2023 Aug;37(8):433-441. doi: 10.1007/s12149-023-01851-y. Epub 2023 Jul 2. Ann Nucl Med. 2023. PMID: 37393373 Review.
-
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.Oncotarget. 2016 Dec 20;7(51):84705-84717. doi: 10.18632/oncotarget.13224. Oncotarget. 2016. PMID: 27835900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials